An endogenous cannabinoid as an endothelium-derived vasorelaxant

Biochemical and Biophysical Research Communications

Volumn 229, Issue 1, 1996, Pages 114-120

  Randall, Michael D ^a   Alexander, Stephen P H ^a   Bennett, Terence ^a   Boyd, E Andrew ^b   Fry, Jeffrey R ^a   Gardiner, Sheila M ^a   Kemp, Philip A ^a   McCulloch, Audrey I ^a   Kendall, David A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; ARACHIDONIC ACID; BRADYKININ; CANNABINOID; CANNABINOID RECEPTOR ANTAGONIST; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; NITRIC OXIDE; RIMONABANT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; THIN LAYER CHROMATOGRAPHY; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALIA;

EID: 0030569513     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1996.1766     Document Type: Article

References (26)

1. 1. Furchgott, R. F., and Zawadzki, J. V. (1980) Nature 288, 373-376.
2. 2. Palmer, R. M. J., Ferrige, A. G., and Moncada, S. (1987) Nature 327, 524-526.
3. 3. Adeagbo, A. S. O., and Triggle, C. R. (1993) J. Cardiovasc. Pharmacol. 21, 423-429.
4. 4. Feletou, M., and Vanhoutte, P. M. (1988) Br. J. Pharmacol. 93, 515-524.
5. 5. Garland, C. J., Plane, F., Kemp, B. K., and Cocks, T. M. (1995) Trends Pharmacol. Sci. 16, 23-30.
6. 6. Plane, F., Pearson, T., and Garland, C. J. (1995) Br. J. Pharmacol. 115, 31-38.
7. 7. Taylor, S. G., and Weston, A. H. (1988). Trends Pharmacol. Sci. 9, 272-274.
8. 8. Kemp, B. K., Smolich, J. J., Ritchie, B. C., and Cocks, T. M. (1995) Br. J. Pharmacol. 116, 2457-2467.
9. 9. Kilpatrick, E. V., and Cocks, T. M. (1994) Br. J. Pharmacol. 112, 557-565.
10. 10. McCulloch, A. I., and Randall, M. D. (1996) Br. J. Pharmacol. 119, 135P.
11. 11. Cohen, R. A., and Vanhoutte, P. M. (1995) Circulation 92, 3337-3349.
12. 12. Bauersachs, J., Hecker, M., and Busse, R. (1994) Br. J. Pharmacol. 113, 1548-1553.
13. 13. Campbell, W. B., Gebremedhin, D., Pratt, P. F., and Harder, D. R. (1996) Circ. Res. 78, 415-423.
14. 14. Hecker, M., Bara, A. T., Bauersachs, J., and Busse, R. (1994) J. Physiol. 481, 407-414.
15. 15. Corriu, C., Félétou, M., Canet, E., and Vanhoutte, P. M. (1996) Br. J. Pharmacol. 117, 607-610.
16. 16. Zygmunt, P. M., Edwards, G., Weston, A. H., Davis, S. C., and Högestätt, E. D. (1996) Br. J. Pharmacol. 118, 1147-1152.
17. 17. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J. C., and Piomelli, D. (1994) Nature 372, 686-691.
18. 18. Rinaldi-Carmona, M., Barth, F., Héauleme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J, Néliat, G., Caput, D., Ferrara, P., Soubrié, P., Breliere, J. C., and Le Fur, G. (1994) FEBS Lett. 350, 240-244.
19. 19. Randall, M. D., and Hiley, C. R. (1988) Br. J. Pharmacol. 94, 977-983.
20. 20. Moore, P. K., al-Swayeh, O. A., Chong, N. W. S., Evans, R. A., and Gibson, A. (1990) Br. J. Pharmacol. 99, 408-412.
21. 21. Deutsch, D. G., and Chin, S. A. (1993) Biochem. Pharmacol. 46, 791-796.
22. 22. Gardiner, S. M., Compton, A. M., Bennett, T., Palmer, R. M. J., and Moncada, S. (1990) Hypertension 15, 486-492.
23. 23. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. (1992) Science 258, 1946-1949.
24. 24. McCulloch, A. I., and Randall, M. D. (1996) Br. J. Pharmacol. 117, 229P.
25. 25. Takenaga, M., Kawasaki, H., Wada, A., and Eto, T. (1995) Circ. Res. 76, 935-941.
26. 26. Nagao, T., and Vanhoutte, P. M. (1992) J. Physiol. 445, 355-367.